SYDNEY (Reuters) - A small Australian medical consulting firm got caught up in an unexpected publicity storm on Thursday after being wrongly named as agreeing with Afghanistan's ruling Taliban to bankroll a $450 million hashish processing plant in the Central Asian country.
A report by Afghanistan's Pajhwok Afghan News said representatives of Australia-based Cpharm had met with counter-narcotic officials at the Ministry of Interior to discuss producing medicines and creams at the factory, offering a legal use of cannabis, which is widespread there.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
